believe study of bimagrumab + semaglutide A phase 2 clinical trial has demonstrated that bimagrumab, when combined with semaglutide, resulted in significant weight loss for trial participants while maintaining lean muscle mass – suggesting a promising approach for 🔬 The BELIEVE Phase 2b

Buy 3+ for $38.00 each and save 5% Buy 5+ for $36.00 each and save 10% Buy 10+ for $34.00 each and save 15% This product is for research purposes only

Syringe types and their markings 100-unit (1 mL) syringe

+ That could extend GLP-1 use into older, frailer or athlete populations and strengthen the case for6/ Stand-alone bimagrumab: a longevity angle Outside the combo, high-dose bimagrumab added lean mass while trimming fat, hinting at a future role in non-obese adults who want to preserve muscle and metabolic health as they agea potential first-in-class anabolic cardiometabolic7/ Limitations and whats next + IV infusions every 12 weeks Current regimen requires clinic visits

12 January 2023